Yu Rong, Li Xiaohong, Yang Jiyu, Wu Wutong
Department of Biopharmaceutics, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2004 Oct;21(5):805-8.
This study was intended to establish a method of preparation of recombinant human insulin, with (His)6-Arg-Arg-human proinsulin (RRhPI) expressed by Escherichia coli. After DEAE-Sepharose Fast Flow ion-exchange chromatography, Sephadex G-25 chromatography and refolding, enzyme cleavage and Superdex 75 size exclusion chromatography,the RRhPI expressed by Escherichia coli in inclusion body form was converted to human insulin. The obtained recombinant human insulin was analyzed by SDS-PAGE, HPLC, amino acid composition analysis and bioidentity test (mouse convulsion test). The results indicate that our obtained preparation is highly purified, active recombinant human insulin.
本研究旨在建立一种制备重组人胰岛素的方法,该方法利用大肠杆菌表达的(His)6-Arg-Arg-人胰岛素原(RRhPI)。经过DEAE-琼脂糖快速流动离子交换色谱、葡聚糖G-25色谱、复性、酶切和Superdex 75尺寸排阻色谱后,以包涵体形式表达的大肠杆菌RRhPI被转化为人胰岛素。通过SDS-PAGE、HPLC、氨基酸组成分析和生物鉴定试验(小鼠惊厥试验)对获得的重组人胰岛素进行分析。结果表明,我们获得的制剂是高度纯化的、有活性的重组人胰岛素。